Antonio Belli Selected Research

4-amino-tetrahydrobiopterin

12/2020	Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study.
1/2020	Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study.
10/2014	Nitric oxide synthase inhibition with the antipterin VAS203 improves outcome in moderate and severe traumatic brain injury: a placebo-controlled randomized Phase IIa trial (NOSTRA).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Belli Research Topics

Disease

40	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2022 - 02/2006
11	Wounds and Injuries (Trauma) 06/2021 - 10/2014
6	Craniocerebral Trauma (Head Injury) 04/2021 - 08/2007
4	Intracranial Hypertension 01/2022 - 06/2014
3	Stroke (Strokes) 01/2021 - 06/2014
3	Hemorrhage 01/2021 - 01/2018
3	Seizures (Absence Seizure) 01/2019 - 01/2018
3	Inflammation (Inflammations) 01/2018 - 05/2007
3	Brain Concussion (Cerebral Concussion) 01/2018 - 01/2010
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2021 - 01/2017
2	Necrosis 05/2019 - 04/2014
2	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 01/2019 - 06/2018
2	Hypoxia (Hypoxemia) 10/2017 - 07/2014
2	Multiple Sclerosis 07/2014 - 07/2009
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Dementia (Dementias) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2021
1	Infarction (Infarctions) 04/2021
1	Chronic Subdural Hematoma 12/2020
1	Hematoma 12/2020
1	Multiple Trauma (Multiple Injuries) 11/2020
1	Body Weight (Weight, Body) 09/2020
1	Atherosclerosis 01/2020
1	Disease Progression 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 12/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018
1	Myocardial Infarction 01/2018
1	Pulmonary Embolism 01/2018
1	Multiple Organ Failure (MODS) 01/2018
1	Leukocytosis (Pleocytosis) 07/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Vitamin D Deficiency 01/2017
1	Acute Subdural Hematoma 04/2016
1	Persistent Vegetative State (Vegetative State) 01/2016
1	Cross Infection (Nosocomial Infection) 01/2015
1	Acute Kidney Injury (Acute Renal Failure) 10/2014
1	Surgical Wound Infection 06/2014
1	Infections 06/2014

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2007
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2014
5	Tranexamic Acid (AMCA)FDA Link 04/2021 - 09/2016
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
4	N-acetylaspartate (N-acetyl aspartate)IBA 03/2014 - 02/2006
3	Biological ProductsIBA 03/2021 - 07/2009
3	4-amino-tetrahydrobiopterinIBA 12/2020 - 10/2014
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2020 - 01/2020
2	AntioxidantsIBA 03/2020 - 04/2014
2	Apolipoproteins E (ApoE)IBA 01/2020 - 02/2014
2	EnzymesIBA 11/2019 - 03/2014
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2019 - 06/2018
2	CystatinsIBA 03/2018 - 10/2017
2	LipopolysaccharidesIBA 07/2017 - 04/2014
2	Adenosine Triphosphate (ATP)IBA 03/2014 - 01/2010
2	Adenosine Diphosphate (ADP)IBA 03/2014 - 01/2010
1	phytobacteriomycin (PBM)IBA 08/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Vitamin K FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020
1	Dextran SulfateIBA 09/2020
1	Oxidoreductases (Dehydrogenase)IBA 11/2019
1	Pyruvic Acid (Pyruvate)IBA 11/2019
1	N-Methylaspartate (NMDA)IBA 05/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2019
1	SteroidsIBA 12/2018
1	Phenytoin (Dilantin)FDA LinkGeneric 06/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2018
1	GasesIBA 10/2017
1	Toll-Like Receptor 2IBA 07/2017
1	CytokinesIBA 07/2017
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 01/2017
1	Amino Acids FDA Link 01/2017
1	CoagulantsIBA 01/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Glial Fibrillary Acidic ProteinIBA 05/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2014
1	NitritesIBA 04/2014

Therapy/Procedure

5	Decompressive Craniectomy 01/2022 - 06/2014
5	Critical Care (Surgical Intensive Care) 06/2021 - 10/2003
4	Therapeutics 01/2022 - 10/2003
2	Craniotomy 01/2022 - 04/2016
2	Time-to-Treatment 01/2021 - 01/2018
2	Length of Stay 01/2015 - 06/2014
1	Low-Level Light Therapy (LLLT) 08/2022
1	Long-Term Care 01/2021
1	Optical Devices 11/2020
1	Duration of Therapy 01/2019
1	Contraindications 12/2018
1	Cerebrospinal Fluid Shunts 12/2018
1	Decompression 04/2016
1	Epidural Injections 01/2016
1	Vagotomy 04/2014